IL150340A0 - Benzoic acid susbstituted benzopyrans for the treatment of atherosclerosis - Google Patents

Benzoic acid susbstituted benzopyrans for the treatment of atherosclerosis

Info

Publication number
IL150340A0
IL150340A0 IL15034002A IL15034002A IL150340A0 IL 150340 A0 IL150340 A0 IL 150340A0 IL 15034002 A IL15034002 A IL 15034002A IL 15034002 A IL15034002 A IL 15034002A IL 150340 A0 IL150340 A0 IL 150340A0
Authority
IL
Israel
Prior art keywords
susbstituted
benzopyrans
atherosclerosis
treatment
benzoic acid
Prior art date
Application number
IL15034002A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL150340A0 publication Critical patent/IL150340A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL15034002A 2001-06-28 2002-06-20 Benzoic acid susbstituted benzopyrans for the treatment of atherosclerosis IL150340A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30171201P 2001-06-28 2001-06-28
US32825401P 2001-10-10 2001-10-10

Publications (1)

Publication Number Publication Date
IL150340A0 true IL150340A0 (en) 2002-12-01

Family

ID=26972559

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15034002A IL150340A0 (en) 2001-06-28 2002-06-20 Benzoic acid susbstituted benzopyrans for the treatment of atherosclerosis

Country Status (12)

Country Link
EP (1) EP1270000A3 (cs)
JP (1) JP2003034638A (cs)
KR (1) KR20030015828A (cs)
CN (1) CN1394602A (cs)
AU (1) AU4239302A (cs)
CA (1) CA2391205A1 (cs)
CZ (1) CZ20022076A3 (cs)
HK (1) HK1049795A1 (cs)
HU (1) HUP0202114A3 (cs)
IL (1) IL150340A0 (cs)
PL (1) PL354770A1 (cs)
SK (1) SK8682002A3 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4476934B2 (ja) * 2003-04-14 2010-06-09 明治乳業株式会社 新規ペプチドおよび免疫賦活剤、機能性食品ならびに機能性食品の製造方法
WO2006011048A1 (en) * 2004-07-22 2006-02-02 Pharmacia Corporation Compositions for treatment of inflammation and pain using a combination of a cox-2 selective inhibitor and a ltb4 receptor antagonist
KR20080016621A (ko) * 2005-06-09 2008-02-21 바이올리폭스 에이비 염증성 질병 치료용 조성물 및 방법
EP3383389B1 (en) * 2015-11-30 2021-04-28 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists
EP3383388B1 (en) 2015-11-30 2021-04-14 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.
DE4228200A1 (de) * 1992-08-25 1994-03-03 Schering Ag Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung
WO1996011925A1 (en) * 1994-10-13 1996-04-25 Pfizer Inc. Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists
MX9702731A (es) * 1994-10-13 1997-06-28 Pfizer Compuestos de benzopirano y benzo fusionados, composiciones que los contienen y uso de los mismos.
EP0833664A1 (en) * 1995-06-12 1998-04-08 G.D. SEARLE & CO. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DK0925292T3 (da) * 1996-09-16 2004-01-12 Pfizer Fremgangsmåder og mellemprodukter til fremstilling af substituerede chromanolderivater
EP0963755A3 (en) * 1998-04-16 2001-03-14 Pfizer Products Inc. Use of benzopyranes for preventing allograft rejection
AU5687199A (en) * 1998-08-24 2000-03-14 Global Vascular Concepts, Inc. Use of anti-angiogenic agents for inhibiting vessel wall injury
JP2003225088A (ja) * 1999-09-10 2003-08-12 Meiji Seika Kaisha Ltd ヒト・ロイコトリエンｂ４第二受容体及びそれをコードするｄｎａ
WO2001068844A2 (en) * 2000-03-17 2001-09-20 Bayer Aktiengesellschaft Regulation of human leukotriene b4-like g protein-coupled receptor

Also Published As

Publication number Publication date
HU0202114D0 (cs) 2002-09-28
SK8682002A3 (en) 2004-08-03
KR20030015828A (ko) 2003-02-25
CZ20022076A3 (cs) 2004-05-12
AU4239302A (en) 2003-01-02
JP2003034638A (ja) 2003-02-07
HK1049795A1 (zh) 2003-05-30
HUP0202114A2 (hu) 2003-01-28
PL354770A1 (en) 2002-12-30
EP1270000A2 (en) 2003-01-02
CN1394602A (zh) 2003-02-05
HUP0202114A3 (en) 2004-07-28
CA2391205A1 (en) 2002-12-28
EP1270000A3 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
GB0121985D0 (en) Tissue engineering scaffolds
AU2002360251A8 (en) Medical devices comprising nanocomposites
AU2002342613A8 (en) Treatment for wounds
HUP0302847A3 (en) Pharmaceutical formulation comprising bicalutamide
KR100642961B9 (ko) 골다공증 치료 및 예방용 비스포스폰산
AU2002303502A1 (en) Improved leads for the treatment of patients with chf
SI1324970T1 (sl) Retinoidi za zdravljenje emfizema
IL161902A0 (en) Pharmaceutical formulation comprising bicalutamide
MXPA03008279A (es) Purificacion de acido 2-nitro-4-metilsulfonilbenzoico.
IL150340A0 (en) Benzoic acid susbstituted benzopyrans for the treatment of atherosclerosis
AU2002233353A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
ZA200402308B (en) NOVEL a-OXYGENATED OR a-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES
GB2380481B (en) Means for treatment of atherosclerosis
ZA200205093B (en) Benzoic acid substituted benzopyrans for the treatment of atherosclerosis.
NO20042664L (no) Karboksylsyrederivat
AU2002316940A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
GB0123765D0 (en) Para-amino benzoic acids
AU2002304733A1 (en) Amino-aza-cyclohexanes for the treatment of malaria
AU2002364178A8 (en) Ownership of part-physical, part-virtual devices
HUP0402343A3 (en) Substituted beta-aminoalcohols used as medicaments
AU2002240930A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
SG122745A1 (en) Compositions for the treatment of malaria
TW518962U (en) Structure for surgical assistance
TJ20010676A (en) Method treatment cirrosis of the liver
AU2002325946A1 (en) Process for the preparation of d-pantothenic acid and/or its salts